Novel mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20060234208A1
SERIAL NO

10527588

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to the finding that TAT interacts with gp120 at the cell surface and enhances HIV-1 entry into host cells. This invention also discloses modulators of this interaction, particularly peptides that mimic the region of gp120 involved in this interaction. These peptides interfere with TAT-mediated enhancement of infection regardless of virus strain, and are therefore suitable for the development in general of broad-range drugs against AIDS and other infectious diseases induced by HIV-1 related pathogens, and specifically for a class of chemicals active in the reduction or abrogation of virus and infectivity spreading.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CREABILIS THERAPEUTICS S P ABIOINDUSTRY PARK VIA RIBES 5 10010 COLLERETTO GIACOSA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bussolino, Federico Torino, IT 3 16
Marchio, Serena Torino, IT 2 15

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation